(Q43036483)

English

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

scientific article published on 6 February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Raymond T Chung

3

object named as

Raymond T Chung

1 reference

Europe PubMed Central

12 November 2017

author name string

Kenneth E Sherman

1

1 reference

Europe PubMed Central

12 November 2017

Susan D Rouster

2

1 reference

Europe PubMed Central

12 November 2017

Natasa Rajicic

4

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

6 February 2002

1 reference

Europe PubMed Central

12 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

12 November 2017

34

1 reference

Europe PubMed Central

12 November 2017

831-837

1 reference

Europe PubMed Central

12 November 2017

6

1 reference

Europe PubMed Central

12 November 2017

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

All Exposed Hemophiliacs Have Markers of HCV

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Prevalence of Antibody to Hepatitis C Virus in Patients Infected with the Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994.

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F339042

21 January 2018

Identifiers

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036483&oldid=1978278355"